Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | HTR2C | P28335 | 1/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.33 |
| ▸ | HRH1 | P35367 | 1/20 | 0.33 |
| ▸ | DRD3 | P35462 | 1/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.33 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.32 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.32 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1283041 | 0.95 | GPR84 (0.35) | GPR84FFAR1HSPD1BLMHSPE1 | |
| SCHEMBL30880240 | 0.93 | GPR84 (0.38) | GPR84FFAR1HSPD1BLMHSPE1 | |
| SCHEMBL9645076 | 0.93 | GPR84 (0.38) | GPR84FFAR1HSPD1BLMHSPE1 | |
| SCHEMBL30880238 | 0.93 | GPR84 (0.38) | GPR84FFAR1HSPD1BLMHSPE1 | |
| SCHEMBL8529065 | 0.93 | GPR84 (0.38) | GPR84FFAR1HSPD1BLMHSPE1 | |
| SCHEMBL7152068 | 0.93 | GPR84 (0.38) | GPR84FFAR1HSPD1BLMHSPE1 | |
| SCHEMBL5137836 | 0.93 | GPR84 (0.38) | GPR84FFAR1HSPD1BLMHSPE1 | |
| SCHEMBL72864 | 0.93 | GPR84 (0.38) | GPR84FFAR1HSPD1BLMHSPE1 | |
| SCHEMBL930252 | 0.93 | GPR84 (0.38) | GPR84FFAR1HSPD1BLMHSPE1 | |
| SCHEMBL10776296 | 0.93 | GPR84 (0.38) | GPR84FFAR1HSPD1BLMHSPE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2120871-B2 | LINKER-BASED LECITHIN MICROEMULSION DELIVERY VEHICLES | ACOSTA-ZARA EDGAR JOEL (CA) | 2017-12-20 | — | — | EP | claimed |
| EP-2120871-B1 | LINKER-BASED LECITHIN MICROEMULSION DELIVERY VEHICLES | ACOSTA-ZARA EDGAR JOEL (CA) | 2014-11-26 | — | — | EP | claimed |
| CN-116981443-A | Fully dilutable self-microemulsifying delivery systems (SMEDDS) for poorly water-soluble polar solutes | 多伦多大学管理委员会 | 2023-10-31 | — | — | CN | disclosed |
| WO-2023140375-A1 | TREATMENT AGENT FOR ELASTIC FIBERS, AND ELASTIC FIBERS | 竹本油脂株式会社 | 2023-07-27 | — | — | WO | disclosed |
| EP-3075796-B1 | INK COMPOSITION FOR INKJET RECORDING AND METHOD FOR PRODUCING SAME, AND INKJET RECORDING METHOD | DNP FINE CHEMICALS CO LTD (JP) | 2019-11-06 | — | — | EP | disclosed |
| US-10253196-B2 | Inkjet recording ink composition, method for producing the same, and inkjet recording method | DNP FINE CHEMICALS CO., LTD. (JP) | 2019-04-09 | — | — | US | disclosed |
| EP-3088482-B1 | INK COMPOSITION FOR INKJET RECORDING, INKJET RECORDING METHOD, AND METHOD FOR PRODUCING PRINTED MATERIAL | DNP FINE CHEMICALS CO LTD (JP) | 2018-11-07 | — | — | EP | disclosed |
| US-9745482-B2 | Inkjet recording ink composition, inkjet recording method, and method for producing printed material | DNP FINE CHEMICALS CO., LTD. (JP) | 2017-08-29 | — | — | US | disclosed |
| US-20160376452-A1 | INKJET RECORDING INK COMPOSITION, METHOD FOR PRODUCING THE SAME, AND INKJET RECORDING METHOD | DNP FINE CHEMICALS CO., LTD. (JP) | 2016-12-29 | — | — | US | disclosed |
| US-20160319141-A1 | INKJET RECORDING INK COMPOSITION, INKJET RECORDING METHOD, AND METHOD FOR PRODUCING PRINTED MATERIAL | DNP FINE CHEMICALS CO., LTD. (JP) | 2016-11-03 | — | — | US | disclosed |
| EP-3088482-A1 | INK COMPOSITION FOR INKJET RECORDING, INKJET RECORDING METHOD, AND METHOD FOR PRODUCING PRINTED MATERIAL | DNP Fine Chemicals Co., Ltd. (JP) | 2016-11-02 | — | — | EP | disclosed |
| US-20130000844-A1 | RUBBER ADHESIVE COMPOSITIONS CONTAINING VINYL PYRIDINE LATEX POLYMERS WITH ALTERNATE NITROGEN MONOMERS | OMNOVA SOLUTIONS INC. | 2013-01-03 | — | — | US | disclosed |
| US-20030078189-A1 | Medicinal compositions for oral use | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2003-04-24 | — | — | US | disclosed |
| EP-1236476-A1 | MEDICINAL COMPOSITIONS FOR ORAL USE | Takeda Chemical Industries, Ltd. (JP) | 2002-09-04 | — | — | EP | disclosed |
| US-5244943-A | Hydrogenation, oil in water emulsion, film strength | NIPPON ZEON CO., LTD. (JP) | 1993-09-14 | — | — | US | disclosed |
| EP-0240697-B1 | NITRILE GROUP-CONTAINING HIGHLY SATURATED POLYMER RUBBER LATEX AND PROCESS FOR PRODUCTION THEREOF | NIPPON ZEON CO., LTD. (JP) | 1993-05-26 | — | — | EP | disclosed |
| EP-0320930-B1 | EMULSION POLYMERISATION PROCESS FOR GRAFT POLYMERS | WACKER-CHEMIE GMBH (DE) | 1993-05-12 | — | — | EP | disclosed |
| EP-0320930-A2 | Emulsion polymerisation process for graft polymers | WACKER-CHEMIE GMBH (DE) | 1989-06-21 | — | — | EP | disclosed |
| EP-0240697-A1 | Nitrile group-containing highly saturated polymer rubber latex and process for production thereof | NIPPON ZEON CO., LTD. (JP) | 1987-10-14 | — | — | EP | disclosed |
| US-4124517-A | ORGANIC ACID SALTS OF MONO- OR DIAMINES IN FLUORINATED HYDROCARBON SOLVENT | DAIKIN KOGYO KABUSHIKI KAISHA (JP) | 1978-11-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030078189-A1 | Medicinal compositions for oral use | CCR5, CXCR3, CCL5 | CHRM1 428/4885AKR1A1 2248/4885CHRM3 166/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.